0 0

2021 AGA Postgraduate Course

9.2 - The changing landscape of fecal microbial transplantation (FMT)

May 1, 2021 8:30am ‐ May 1, 2021 8:50am

Overview
Comments

Presentation style: Interview

Learning Objectives:

To gain an understanding of the evolution of FMT over time.
To describe the FDA regulations surrounding FMT.
To develop an appreciation for how COVID-19 has affected use of FMT in clinical practice.
To recognize the potential indications for FMT and understand the efficacy of FMT in the treatment of C. difficile infection (CDI), IBD and IBS

Interviewee(s):

Olga C. Aroniadis, MD, MS, Associate Professor of Clinical Medicine, Stony Brook University Medical Center

Interviewer(s):

Dr. Ari M. Grinspan, MD, Associate Professor of Medicine, Icahn School of Medicine at Mount Sinai

You must be logged in and own this session in order to post comments.